← 返回

Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization Study.

Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization Study.

期刊: J Am Coll Cardiol 日期: 2026-01-01 PMID: 42017882 DOI: 10.1016/j.jacc.2026.02.5093 浏览: 141
作者: Sunderland Nicholas, Asselin Geraldine, Henry Albert, Nelson Christopher P, Lemieux Perreault Louis-Philippe, Asselbergs Folkert W, Boersma Eric, Cappola Thomas P, Chazara Olympe, Chutkow William, Cyr Marie-Christyne, Gkatzionis Apostolos, Gui Hongsheng, Haefliger Carolina, Hedman Åsa K, Hillege Hans, Hyde Craig L, Kamanu Frederick K, Kardys Isabella, Koekemoer Andrea L, Kraus William E, Lang Chim C, Malarstig Anders, Margulies Kenneth B, Marston Nicholas A, Melloni Giorgio E M, Morley Michael P, O'Donoghue Michelle L, Owens Anjali T, Paul Dirk S, Tilling Kate, van der Harst Pim, van Setten Jessica, van Vugt Marion, Verweij Niek, Veluchamy Abirami, Wallentin Lars, Wang Xiaosong, Xing Heming, Yang Yifan, White Harvey D, Zannad Faiez, Smith J Gustav, Brunner-La Rocca Hans-Peter, Lanfear David E, Mann Douglas L, de Denus Simon, Tardif Jean-Claude, Voors Adriaan A, Samani Nilesh J, Ellinor Patrick T, Ruff Christian T, Sabatine Marc S, Sattar Naveed, McMurray John J V, Paternoster Lavinia, Dubé Marie-Pierre, Lumbers R Thomas
Nicholas, S., Geraldine, A., Albert, H., P, N.C., Louis-Philippe, L.P., W, A.F., Eric, B., P, C.T., Olympe, C., William, C., Marie-Christyne, C., Apostolos, G., Hongsheng, G., Carolina, H., K, H.Å., Hans, H., L, H.C., K, K.F., Isabella, K., . . . Thomas, L.R. (2026). Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization Study.. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2026.02.5093
Nicholas S, Geraldine A, Albert H, P NC, Louis-Philippe LP, W AF, et al. Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization Study.. J Am Coll Cardiol. 2026; doi: 10.1016/j.jacc.2026.02.5093
Nicholas S, Geraldine A, Albert H, et al. Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization Study.[J]. J Am Coll Cardiol. 2026. DOI: 10.1016/j.jacc.2026.02.5093.
@article{nicholas2026,
  author = {Sunderland Nicholas and Asselin Geraldine and Henry Albert and Nelson Christopher P and Lemieux Perreault Louis-Philippe and Asselbergs Folkert W and Boersma Eric and Cappola Thomas P and Chazara Olympe and Chutkow William and Cyr Marie-Christyne and Gkatzionis Apostolos and Gui Hongsheng and Haefliger Carolina and Hedman Åsa K and Hillege Hans and Hyde Craig L and Kamanu Frederick K and Kardys Isabella and Koekemoer Andrea L and Kraus William E and Lang Chim C and Malarstig Anders and Margulies Kenneth B and Marston Nicholas A and Melloni Giorgio E M and Morley Michael P and O'Donoghue Michelle L and Owens Anjali T and Paul Dirk S and Tilling Kate and van der Harst Pim and van Setten Jessica and van Vugt Marion and Verweij Niek and Veluchamy Abirami and Wallentin Lars and Wang Xiaosong and Xing Heming and Yang Yifan and White Harvey D and Zannad Faiez and Smith J Gustav and Brunner-La Rocca Hans-Peter and Lanfear David E and Mann Douglas L and de Denus Simon and Tardif Jean-Claude and Voors Adriaan A and Samani Nilesh J and Ellinor Patrick T and Ruff Christian T and Sabatine Marc S and Sattar Naveed and McMurray John J V and Paternoster Lavinia and Dubé Marie-Pierre and Lumbers R Thomas},
  title = {Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization Study.},
  journal = {J Am Coll Cardiol},
  year = {2026},
  doi = {10.1016/j.jacc.2026.02.5093},
  note = {PMID: 42017882},
}
TY  - JOUR
AU  - Sunderland Nicholas
AU  - Asselin Geraldine
AU  - Henry Albert
AU  - Nelson Christopher P
AU  - Lemieux Perreault Louis-Philippe
AU  - Asselbergs Folkert W
AU  - Boersma Eric
AU  - Cappola Thomas P
AU  - Chazara Olympe
AU  - Chutkow William
AU  - Cyr Marie-Christyne
AU  - Gkatzionis Apostolos
AU  - Gui Hongsheng
AU  - Haefliger Carolina
AU  - Hedman Åsa K
AU  - Hillege Hans
AU  - Hyde Craig L
AU  - Kamanu Frederick K
AU  - Kardys Isabella
AU  - Koekemoer Andrea L
AU  - Kraus William E
AU  - Lang Chim C
AU  - Malarstig Anders
AU  - Margulies Kenneth B
AU  - Marston Nicholas A
AU  - Melloni Giorgio E M
AU  - Morley Michael P
AU  - O'Donoghue Michelle L
AU  - Owens Anjali T
AU  - Paul Dirk S
AU  - Tilling Kate
AU  - van der Harst Pim
AU  - van Setten Jessica
AU  - van Vugt Marion
AU  - Verweij Niek
AU  - Veluchamy Abirami
AU  - Wallentin Lars
AU  - Wang Xiaosong
AU  - Xing Heming
AU  - Yang Yifan
AU  - White Harvey D
AU  - Zannad Faiez
AU  - Smith J Gustav
AU  - Brunner-La Rocca Hans-Peter
AU  - Lanfear David E
AU  - Mann Douglas L
AU  - de Denus Simon
AU  - Tardif Jean-Claude
AU  - Voors Adriaan A
AU  - Samani Nilesh J
AU  - Ellinor Patrick T
AU  - Ruff Christian T
AU  - Sabatine Marc S
AU  - Sattar Naveed
AU  - McMurray John J V
AU  - Paternoster Lavinia
AU  - Dubé Marie-Pierre
AU  - Lumbers R Thomas
TI  - Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization Study.
T2  - J Am Coll Cardiol
PY  - 2026
DO  - 10.1016/j.jacc.2026.02.5093
AN  - PMID:42017882
ER  - 

摘要

Excess adiposity, most commonly indexed through body mass index (BMI), is strongly associated with the development of heart failure (HF). Weight loss therapies improve outcomes in patients with obesity and HF with preserved left ventricular ejection fraction (LVEF), but their effects in HF with reduced LVEF remain unclear. The aim of this work is to determine whether higher BMI is associated with adverse clinical outcomes in patients with HF and whether there is effect modification by LVEF subgroup. Two-sample Mendelian randomization (MR) was used, with genome-wide significant loci associated with BMI as instrumental variables and outcome data from a genome-wide association study (GWAS) of time-to-event clinical outcomes in patients with HF. A total of 50,636 individuals of European ancestry with established HF from 22 cohorts were included in the genetic analysis: 12 HF trials, 1 prospective case-cohort study, 9 cohorts nested within non-HF cardiovascular trials, and 1 population-based cohort derived from the UK Biobank. The exposure was genetically predicted BMI and the outcome measures were all-cause mortality and a composite of cardiovascular mortality or HF hospitalization. Genetic associations for the outcomes were derived from our GWAS and MR was used to estimate the unbiased association of genetically predicted BMI with these clinical outcomes. The mean BMI was 29.2 ± 5.8 kg/m2. Over a median follow-up of 27.0 months, all-cause mortality occurred in 11,454 patients (23%), and 11,360 participants (22%) experienced the composite endpoint. Genetically predicted BMI was associated with an increased rate of both all-cause mortality (HR per SD [4.8 BMI units] 1.21; 95% CI: 1.13-1.29; P = 9 × 10-8) and the composite outcome (HR 1.29; 95% CI: 1.20-1.38; P = 8 × 10-13). Associations were consistent across LVEF ≤40% and >40%: for all-cause mortality, HR: 1.16 (95% CI: 0.99-1.37) and 1.20 (95% CI: 0.94-1.53); and for the composite outcome, HR: 1.30 (95% CI: 1.15-1.48) and 1.57 (95% CI: 1.29-1.91), respectively. Among patients with HF, higher BMI was associated with increased all-cause mortality and cardiovascular death or HF hospitalization, supporting the potential role of weight-management strategies across the ejection fraction spectrum.

AI 智能解读

相关文献

返回分类: 心衰 查看原文 (DOI)
已选择 0 篇文献